Skip to main content

Advertisement

Log in

A giant pancreatic serous microcystic adenoma with 20 years follow-up

  • Case Management and Clinical Consequences
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Background and aims

There is only little information about the spontaneous course of large pancreatic serous tumours. We followed up a white woman with a giant serous microcystic adenoma over more than 20 years.

Case report

At first clinical presentation, in 1986, the tumour measured 4.5 cm in diameter. Two years later, it measured 6 cm and was considered as non-resectable at laparotomy. A biopsy was obtained, and the tumour was diagnosed as lymphangioma, based on hematoxylin and eosin-staining. During the follow-up, the tumour progressively increased in size, measuring 12 cm in diameter in 1993 and 17 cm in 2000. Thus, an average growth rate of 0.83 cm per year was calculated. Unspecific abdominal discomfort and pain were the leading clinical symptoms. A colonic resection was necessary because of compression by the tumour in 1993. Portal hypertension was detected at laparotomy. Finally, the initial biopsy specimen was re-evaluated, using immunohistochemistry, and the final diagnosis of a serous microcystic adenoma was made.

Conclusion

This unique case demonstrates that the spontaneous course of serous microcystic adenoma of the pancreas may be favourable even with huge tumour size and that immunohistochemistry may prove a valuable tool for differential diagnosis of cystic pancreatic lesions. Due to their size and progressive, space-occupying growth, these biologically benign tumours may cause injury to adjacent organs and thus clinical symptoms. For this reason, curative surgical resection is the treatment of choice for this tumour entity except for small, asymptomatic lesions, which do not require intervention. When radical resection is impossible, palliative surgery may improve the quality of life for several years. The risk of malignant transformation seems to be low even in the long-term course.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Box JC, Douglas HO (2000) Management of cystic neoplasms of the pancreas. Am Surgeon 66:495–501

    PubMed  CAS  Google Scholar 

  2. Sarr MG, Kendrick ML, Nagorney DM, Thompson GB, Farley DR, Farnell MB (2001) Cystic neoplasms of the pancreas: benign to malignant epithelial neoplasms. Surg Clin North Am 81:497–509

    Article  PubMed  CAS  Google Scholar 

  3. Spinelli KS, Fromwiller TE, Daniel RA, Kiely JM, Nakeeb A, Komorowski RA, Wilson SD, Pitt HA (2004) Cystic pancreatic neoplasms. Observe or operate. Ann Surg 239:651–659

    Article  PubMed  Google Scholar 

  4. Sarr MG, Murr M, Smyrk TC, Yeo CJ, Fernandez-del-Castillo C, Hawes RH, Freeny PC (2003) Primary cystic neoplasms of the pancreas: neoplastic disorders of emerging importance—current state-of-the-art and unanswered questions. J Gastrointest Surg 7:417–428

    Article  PubMed  Google Scholar 

  5. Vortmeyer AO, Lubensky IA, Fogt F, Linehan WM, Khettry U, Zhuang Z (1997) Allelic deletion and mutation of the von Hippel–Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas. Am J Pathol 151:951–956

    PubMed  CAS  Google Scholar 

  6. Hamilton SR, Aaltonen LA (eds) (2000) Pathology and genetics of tumours of the digestive system. IARC, Lyon

    Google Scholar 

  7. Horvath KD, Chabot JA (1999) An aggressive resectional approach to cystic neoplasms of the pancreas. Am J Surg 178:269–274

    Article  PubMed  CAS  Google Scholar 

  8. Cheng CK, Kanamaru T, Ueno N, Tanaka KI, Idei Y, Nishida Y, Yamamoto M (2001) A case of pancreatic serous cystadenoma obstructing the distal pancreatic duct. Oncol Rep 8:811–813

    PubMed  CAS  Google Scholar 

  9. Heim D, Sutter PM, Mattli J, Matter P (1994) Rupturiertes cystadenom des pankreas. Chirurg 65:68–71

    PubMed  CAS  Google Scholar 

  10. Marincek B (1995) Serous cystadenoma of the pancreas tail with extensive necrosis and fresh post-traumatic bleeding. Schweiz Rundsch Med Praxis 84:213–215

    CAS  Google Scholar 

  11. Barbe L, Levy P, Sauvanet A, Flejou JF, Belghiti J, Bernades P (1995) Serous cystadenoma of the pancreas revealed by choledochal stenosis. Gastroenterol Clin Biol 19:848–849

    PubMed  CAS  Google Scholar 

  12. Abe H, Kubota K, Mori M, Miki K, Minagawa M, Noie T, Kimura W, Makuuchi M (1998) Serous cystadenoma of the pancreas with invasive growth: benign or malignant? Am J Gastroenterol 93:1963–1966

    Article  PubMed  CAS  Google Scholar 

  13. Kamei K, Funabiki T, Ochiai M, Amano H, Kasahara M, Sakamoto T (1991) Multifocal pancreatic serous cystadenoma with atypical cells and focal perineural invasion. Int J Pancreatol 10:161–172

    PubMed  CAS  Google Scholar 

  14. El Nakadi B, Greuse M, Debaize JP, Salhadin A (1992) A new complication of cystic neoplasms of the pancreas: cysto-duodenal fistula. Acta Chir Belg 92:52–54

    PubMed  Google Scholar 

  15. Haarmann W, Mittelkötter U, Smektala R (1997) Monströses seröses Zystadenomrezidiv des Pankreas. Zentralbl Chir 122:122–125

    PubMed  CAS  Google Scholar 

  16. Ohta T, Nagakawa T, Itoh H, Fonseca L, Miyazaki I, Terada T (1993) A case of serous cystadenoma of the pancreas with focal malignant changes. Int J Pancreatol 14:283–289

    PubMed  CAS  Google Scholar 

  17. Fujii H, Kubo S, Hirohashi K, Kinoshita H, Yamamoto T, Wakasa K (1998) Serous cystadenoma of the pancreas with atypical cells. Int J Pancreatol 23:165–169

    PubMed  CAS  Google Scholar 

  18. Tseng JF, Warshaw AL, Sahani DV, Lauwers GY, Rattner DW, Fernandez-del Castillo C (2005) Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment. Ann Surg 242:413–421

    PubMed  Google Scholar 

  19. Klöppel G, Kosmahl M (2001) Cystic lesions and neoplasms of the pancreas. The features are becoming clearer. Pancreatology 1:648–655

    Article  PubMed  Google Scholar 

  20. Kamei K, Funabiki T, Ochiai M, Amano H, Marugami Y, Kasahara M, Sakamoto T (1992) Some considerations on the biology of pancreatic serous cystadenoma. Int J Pancreatol 11:97–104

    PubMed  CAS  Google Scholar 

  21. Widmaier U, Mattfeldt T, Siech M, Beger HG (1996) Serous cystadenocarcinoma of the pancreas. Int J Pancreatol 20:135–139

    PubMed  CAS  Google Scholar 

  22. Le Borgne J, de Calan L, Partensky C (1999) Cystadenomas and cystadenocarcinomas of the pancreas: a multiinstitutional retrospective study of 398 cases. French Surgical Association. Ann Surg 230:152–161

    Article  PubMed  Google Scholar 

  23. Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, Yamaguchi K, Yamao K, Matsuno S (2006) International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 6:17–32

    Article  PubMed  Google Scholar 

  24. Siech M, Tripp K, Schmidt-Rohlfing B, Mattfeldt T, Widmaier U, Gansauge F, Görich J, Beger HG (1998) Cystic tumours of the pancreas: diagnostic accuracy, pathologic observations and surgical consequences. Langenbecks Arch Surg 383:56–61

    Article  PubMed  CAS  Google Scholar 

  25. Kim SG, Wu TT, Lee JH, Yun YK, Issa JP, Hamilton SR, Rashid A (2003) Comparison of epigenetic and genetic alterations in mucinous cystic neoplasm and serous microcystic adenoma of pancreas. Mod Path 16:1086–1094

    Article  Google Scholar 

  26. Moore PS, Zamboni G, Brighenti A, Lissandrini D, Antonello D, Capelli P, Rigaud G, Falconi M, Scarpa A (2001) Molecular characterization of pancreatic serous microcystic adenomas. Evidence for a tumor suppressor gene on chromosome 10 q. Am J Pathol 158:317–321

    PubMed  CAS  Google Scholar 

  27. Moore PS, Beghelli S, Zamboni G, Scarpa A (2003) Genetic abnormalities in pancreatic cancer. Molec Cancer 2:7–12

    Article  Google Scholar 

  28. Gerdes B, Wild A, Wittenberg J, Barth P, Ramaswamy A, Kersting M, Lüttges J, Klöppel G, Bartsch DK (2003) Tumor-suppressing pathways in cystic pancreatic tumors. Pancreas 26:42–48

    Article  PubMed  CAS  Google Scholar 

  29. Lüttges J, Galehdari H, Bröcker V, Schwarte-Waldhoff I, Henne-Bruns D, Klöppel G, Schmiegel W, Hahn SA (2001) Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis. Am J Pathol 158:1677–1683

    PubMed  Google Scholar 

  30. Ishikawa T, Nakao A, Nomoto S, Hosono J, Harada A, Nonami T, Takagi H (1998) Immunohistochemical and molecular biological studies of serous cystadenoma of the pancreas. Pancreas 16:40–44

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hans-Ulrich Schulz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schulz, HU., Kellner, U., Kahl, S. et al. A giant pancreatic serous microcystic adenoma with 20 years follow-up. Langenbecks Arch Surg 392, 209–213 (2007). https://doi.org/10.1007/s00423-006-0146-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-006-0146-1

Keywords

Navigation